CHRONIC GRANULOMATOUS DISEASE
Clinical trials for CHRONIC GRANULOMATOUS DISEASE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC GRANULOMATOUS DISEASE trials appear
Sign up with your email to follow new studies for CHRONIC GRANULOMATOUS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists attempt gene fix for rare immune disease
⭐️ CURE ⭐️ TerminatedThis early-stage trial aimed to test a gene therapy for males with a rare inherited immune disorder called chronic granulomatous disease (CGD). The approach involved collecting a patient's own blood stem cells, using a modified virus to insert a corrected gene into them, and then…
Matched conditions: CHRONIC GRANULOMATOUS DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Helixmith Co., Ltd. • Aim: ⭐️ CURE ⭐️
Last updated Mar 23, 2026 15:28 UTC
-
Experimental transplant offers hope for rare immune disease cure
⭐️ CURE ⭐️ OngoingThis early-phase study is testing whether a bone marrow transplant from a partially matched family member can cure chronic granulomatous disease (CGD), a rare immune disorder that causes severe infections. Researchers are using a special combination of medications and radiation b…
Matched conditions: CHRONIC GRANULOMATOUS DISEASE
Phase: EARLY_PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ CURE ⭐️
Last updated Mar 19, 2026 14:56 UTC
-
Scientists test One-Time gene fix for 'Bubble Boy' disease
Disease control ENROLLING_BY_INVITATIONThis study is testing a new gene therapy for people with a rare, inherited immune disorder called p47 chronic granulomatous disease (CGD). Doctors will collect a patient's own blood stem cells, add a corrected copy of the missing gene in a lab, and then return the modified cells …
Matched conditions: CHRONIC GRANULOMATOUS DISEASE
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Apr 01, 2026 20:26 UTC
-
New hope for controlling debilitating inflammation in rare immune disease
Disease control ENROLLING_BY_INVITATIONThis early-stage study is testing whether the drug tofacitinib is safe and can help control severe inflammation in adults with chronic granulomatous disease (CGD). CGD is a rare immune disorder where people get frequent infections and often develop painful inflammation in their g…
Matched conditions: CHRONIC GRANULOMATOUS DISEASE
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope: rebuilding broken immune systems with donor cells
Disease control OngoingThis study is testing a treatment to rebuild the immune system in people with severe inherited immune deficiencies. Patients receive stem cells from a donor, which are meant to grow into healthy new immune cells. The goal is to control the disease and reduce life-threatening infe…
Matched conditions: CHRONIC GRANULOMATOUS DISEASE
Phase: NA • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Gentler transplant offers hope for kids with 'Bubble Boy' and other immune diseases
Disease control OngoingThis study is testing a less intense stem cell transplant procedure for children and young adults with rare disorders where the immune system doesn't work properly. The goal is to use a milder treatment to help the patient's body accept the donor's healthy immune cells with fewer…
Matched conditions: CHRONIC GRANULOMATOUS DISEASE
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC